492027 Sigma-AldrichNRG1 Isoform SMDF, Human, Recombinant
Productos recomendados
Descripción
Replacement Information |
---|
Tabla espec. clave
Purity |
---|
>95% by SDS-PAGE |
Precios y disponibilidad
Número de referencia | Disponiblidad | Embalaje | Cant./Env. | Precio | Cantidad | |
---|---|---|---|---|---|---|
492027-25UG |
|
Frasco de vidrio | 25 μg |
|
— |
Product Information | |
---|---|
Form | Lyophilized |
Formulation | Lyophilized from 0.2 µm filtered PBS, BSA. |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Biological activity | ED₅₀ = 1-5 ng/ml as measured in a serum-free proliferation assay using MCF-7 human breast adenocarcinoma cells. |
Purity | >95% by SDS-PAGE |
Physicochemical Information | |
---|---|
Contaminants | Endotoxin: ≤1.0 EU/µg protein |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information |
---|
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Número de referencia | GTIN |
492027-25UG | 04055977273526 |
Documentation
NRG1 Isoform SMDF, Human, Recombinant Ficha datos de seguridad (MSDS)
Título |
---|
NRG1 Isoform SMDF, Human, Recombinant Certificados de análisis
Cargo | Número de lote |
---|---|
492027 |
Referencias bibliográficas
Visión general referencias |
---|
Meyer, D. et al. 1997. Development 124, 3575. Yarden, Y. and D. Wen 1994. in Guidebook to Cytokinesand Their Receptors, N.A. Nicola, Ed., Oxford University Press, p. 146. Karey, K.P., et al. 1988. Cancer Res. 48, 4083. |